Cytochrome P450 and cyclooxygenase metabolites contribute to the endothelin-1 afferent arteriolar vasoconstrictor and calcium responses

John D. Imig, Bao Thang Pham, Elizabeth A. LeBlanc, K. Malla Reddy, J R Falck, Edward W. Inscho

Research output: Contribution to journalArticlepeer-review

79 Scopus citations

Abstract

Arachidonic acid metabolites contribute to the endothelin-1 (ET-1)- induced decrease in renal blood flow, but the vascular sites of action are unknown. Experiments performed in vitro used the rat juxtamedullary nephron preparation combined with videomicroscopy. The response of afferent arterioles to ET-1 was determined before and after cytochrome P450 (CYP450) or cyclooxygenase (COX) inhibition. Afferent arteriolar diameter averaged 20±1 μm (n=17) at a renal perfusion pressure of 100 mm Hg. Superfusion with 0.001 to 10 nmol/L ET-1 caused a graded decrease in diameter of the afferent arteriole. Vessel diameter decreased by 30±2% and 41±2% in response to 1 and 10 nmol/L ET-1, respectively. The afferent arteriolar response to ET-1 was significantly attenuated during administration of the CYP450 hydroxylase inhibitor N-methylsulfonyl-12,12-dibromododec-11-enamide (DDMS), such that afferent arteriolar diameter decreased by 19±3% and 22±3% in response to 1 and 10 nmol/L ET-1, respectively. COX inhibition also greatly attenuated the vasoconstriction elicited by ET-1, whereas the CYP450 epoxygenase inhibitor N-methylsulfonyl-6-(2-proparglyoxyphenyl) hexanamide enhanced the ET-1- mediated vascular response. Additional studies were performed using freshly isolated smooth muscle cells prepared from preglomerular microvessels. Renal microvascular smooth muscle cells were loaded with the calcium-sensitive dye fura 2 and studied by use of single-cell fluorescence microscopy. Basal renal microvascular smooth muscle cell [Ca2+](i) averaged 95±3 nmol/L (n=42). ET-1 (10 nmol/L) increased microvascular smooth muscle cell [Ca2+](i) to a peak value of 731±75 nmol/L before stabilizing at 136±8 nmol/L. Administration of DDMS or the COX inhibitor indomethacin significantly attenuated the renal microvascular smooth muscle cell calcium response to ET- 1. These data demonstrate that CYP450 hydroxylase and COX arachidonic acid metabolites contribute importantly to the afferent arteriolar diameter and renal microvascular smooth muscle cell calcium responses elicited by ET-1.

Original languageEnglish (US)
Pages (from-to)307-312
Number of pages6
JournalHypertension
Volume35
Issue number1 II
DOIs
StatePublished - Jan 2000

Keywords

  • Cyclooxygenase
  • Cytochrome P450
  • Cytosolic calcium
  • Endothelin-1
  • Microcirculation
  • Renal hemodynamics

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Cytochrome P450 and cyclooxygenase metabolites contribute to the endothelin-1 afferent arteriolar vasoconstrictor and calcium responses'. Together they form a unique fingerprint.

Cite this